These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 18234380

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Discrimination of viable and dead Vibrio vulnificus after refrigerated and frozen storage using EMA, sodium deoxycholate and real-time PCR.
    Lee JL, Levin RE.
    J Microbiol Methods; 2009 Nov; 79(2):184-8. PubMed ID: 19733199
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans.
    Jainkittivong A, Butsarakamruha T, Langlais RP.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):394-8. PubMed ID: 19716507
    [Abstract] [Full Text] [Related]

  • 48. The Candida albicans Ddr48 protein is essential for filamentation, stress response, and confers partial antifungal drug resistance.
    Dib L, Hayek P, Sadek H, Beyrouthy B, Khalaf RA.
    Med Sci Monit; 2008 Jun; 14(6):BR113-121. PubMed ID: 18509269
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. In situ quantification of biocide efficacy using GFP transformed Aureobasidium pullulans.
    Sabev HA, Handley PS, Robson GD.
    J Appl Microbiol; 2004 Jun; 97(6):1132-9. PubMed ID: 15546403
    [Abstract] [Full Text] [Related]

  • 53. Catalase gene disruptant of the human pathogenic yeast Candida albicans is defective in hyphal growth, and a catalase-specific inhibitor can suppress hyphal growth of wild-type cells.
    Nakagawa Y.
    Microbiol Immunol; 2008 Jan; 52(1):16-24. PubMed ID: 18352908
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
    Claudino AL, Peixoto RF, Melhem MS, Szeszs MW, Lyon JP, Chavasco JK, Franco MC.
    Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388
    [Abstract] [Full Text] [Related]

  • 57. Penetration of antifungal agents through Candida biofilms.
    Douglas LJ.
    Methods Mol Biol; 2009 Apr; 499():37-44. PubMed ID: 19152037
    [Abstract] [Full Text] [Related]

  • 58. Rapid viability assessment of yeast cells using vital staining with 2-NBDG, a fluorescent derivative of glucose.
    Oh KB, Matsuoka H.
    Int J Food Microbiol; 2002 Jun 05; 76(1-2):47-53. PubMed ID: 12038577
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Comparison of methods for measuring viable E. coli cells during cultivation: great differences in the early and late exponential growth phases.
    Wang H, Cheng H, Wei D, Wang F.
    J Microbiol Methods; 2011 Jan 05; 84(1):140-3. PubMed ID: 21078347
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.